GlaxoSmithKline PLC Director/PDMR Shareholding (0676F)

TIDMGSK

RNS Number : 0676F

GlaxoSmithKline PLC

15 February 2018

GlaxoSmithKline plc (the 'Company')

2018 Award under the Deferred Investment Award Programme

Notional Award

On 14 February, 2018 the Company granted an award over notional Ordinary Shares to a Person Discharging Managerial Responsibilities ('PDMR') under the GlaxoSmithKline Deferred Investment Award programme.

The PDMR joined the Company in September 2017 and the award is made under the terms of the employment offer. The award will vest 25% on each of 4 September, 2020, 4 September, 2021, 4 September, 2022, and 4 September, 2023.

Under the programme, awards are made over notional Ordinary Shares with vesting phased over a specified period to provide long-term alignment with shareholders. Vesting is subject to the PDMR not having served the Company notice or having been terminated by the Company for cause. Notional dividends will accrue on the award during the vesting period through dividend reinvestment in additional notional shares. On vesting, the award and accrued dividends will be paid in cash. Executive Directors are not eligible to receive awards under the programme.

Transaction notification

 
 1.    Details of PDMR/person closely associated 
        with them ('PCA') 
====  ========================================================================= 
 a)    Name                         Mr L Miels 
====  ============================  =========================================== 
 b)    Position/status              President, Global Pharmaceuticals 
====  ============================  =========================================== 
 c)    Initial notification/        Initial Notification 
        amendment 
====  ============================  =========================================== 
 2.    Details of the issuer, emission allowance 
        market participant, auction platform, auctioneer 
        or auction monitor 
====  ========================================================================= 
 a)    Name                         GlaxoSmithKline plc 
====  ============================  =========================================== 
 b)    LEI                          5493000HZTVUYLO1D793 
====  ============================  =========================================== 
 3.    Details of the transaction(s): section 
        to be repeated for (i) each type of instrument; 
        (ii) each type of transaction; (iii) each 
        date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================= 
 a)    Description                   Ordinary shares of 25 pence each 
        of the financial              ('Ordinary Shares') 
        instrument 
                                      ISIN: GB0009252882 
====  ============================  =========================================== 
 b)    Nature of                    A restricted award of notional 
        the transaction              Ordinary Shares under the Company's 
                                     Deferred Investment Award programme. 
====  ============================  =========================================== 
 c)    Price(s)                       Price(s)            Volume(s) 
        and 
        volume(s) 
====  ============================   ==================  ==================== 
    GBP15.00                                              90,266.667 
   ====================================================  ==================== 
 
 d)    Aggregated                   n/a (single transaction) 
        information 
==== 
  Aggregated 
   volume Price 
 =================================================  =========================== 
 e)    Date of the                  2018-02-14 
        transaction 
====  ============================  =========================================== 
 f)    Place of                     n/a 
        the transaction 
====  ============================  =========================================== 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHVELFFVLFBBBD

(END) Dow Jones Newswires

February 15, 2018 13:09 ET (18:09 GMT)